This is a routine and immaterial insider sale notice from a venture capital fund. No trading action is warranted based on this filing alone. Monitor for any actual sales on Form 4 or changes in insider selling patterns.
IRON drugs
IRON drug pipeline →How the stock moved after the report
NEUTRAL VIEWSTOCK BELOW ENTRY AT T+20- T+0 · Sep 3 $79.37entry
- T+1 · 2mo ago −0.18%α +0.21% · $79.23
- T+5 · 2mo ago −11.73%α −10.58% · $70.06
- T+20 · 7w ago −17.53%α −16.41% · $65.46
- T+51 · todayOpen
- T+60 · in 13d Pending
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
Atlas Venture Fund XII, L.P., a venture capital insider, filed a Form 144 notice of intent to sell 513 shares of Disc Medicine (IRON) common stock, with an approximate market value of $40,358. This is a very small sale relative to the company's $3.0B market cap and the insider's likely holdings, and is likely a routine portfolio adjustment by a venture investor, not a signal of deteriorating fundamentals. The filing is neutral and low-impact, with no material read-through for the stock.
Key Facts
- Atlas Venture Fund XII, L.P. filed a Form 144 to sell 513 shares of Disc Medicine (IRON) common stock.
- The approximate market value of the proposed sale is $40,358.
- The shares were acquired in a private placement on May 1, 2020.
- The filing is an advance notice of intent to sell, not a completed transaction.
Financial Impact
Proposed sale of 513 shares valued at approximately $40,358, a negligible amount relative to the company's $3.0B market cap.
Risk Factors
- The sale is not completed yet; the insider may choose not to sell.
- No material risk to the company or stock from this filing.
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 3 SEC documents filed with EDGAR.
| Document | Accession Number |
|---|---|
| 144 Filing (Primary) | 0001628280-26-060165 |
| Document: 0001628280-26-060165-index.html | 0001628280-26-060165 |
| Document: 0001628280-26-060165.txt | 0001628280-26-060165 |
Track record
43 reports on IRON
7 of 10 bullish or bearish reports moved the stock their way by T+20. Best: +20.07% at T+20 after the Sep 3, 2026 report. 11 of 16 went positive at some point.
Filters
- Nov 10, 20266d ago 144 Neutral 2/10 Entry $87.08 Now $76.59 −12.05% settles Dec 10
- Nov 5, 202611d ago 424B5 Bearish 5/10 Entry $78.91 Now $76.59 +2.94% settles Dec 7
- Nov 5, 202611d ago 8-K Neutral 5/10 No price data
- Nov 5, 202611d ago Press Release Bullish 7/10 Entry $78.47 Now $76.59 −2.40% settles Dec 4
- Nov 4, 202612d ago Press Release Neutral 3/10 Entry $83.28 Now $76.59 −8.03% settles Dec 3
- Nov 3, 202613d ago Institutional Cluster Neutral 3/10 Entry $81.16 Now $76.59 −5.63% settles Dec 2
- Oct 26, 202621d ago SC 13D/A Neutral 3/10 Entry $79.90 Now $76.59 −4.14% settles Nov 24
- Oct 22, 202625d ago 8-K Bearish 6/10 Entry $74.51 Now $76.59 −2.79% settles Nov 20
- Oct 21, 202626d ago 424B5 Bearish 6/10 Entry $75.03 Now $76.59 −2.08% settles Nov 19
- Oct 21, 202626d ago 144 Neutral 2/10 Entry $75.03 Now $76.59 +2.08% settles Nov 19
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers